ClinicalTrials.gg
Not yet recruitingNCT07940673ANTICIPATEUpdated Nov 17, 2026

Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game

An interventional study of Narrative Video Game in Alzheimer's Disease and Related Dementias and Advance Care Planning, sponsored by University of Pittsburgh. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Other

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 15 studies in Alzheimer Disease by University of Pittsburgh — 2 open to participants now, 3 under way, none of them phase 3. Alzheimer Disease · University of Pittsburgh.

Planned enrollment
9th of 14
60 · median 86
Started
2026
the only one that year
No phase
11 of 15
2 open now
Registered
15th of 15
by date

Among the 15 studies in Alzheimer Disease by University of Pittsburgh, this one is the 9th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2026, is one of 11 with no phase, and was the 15th registered.

Alzheimer Disease

3,970 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.

Browse Alzheimer Disease studies →

Open to participants now

2 of the 15 studies in Alzheimer Disease by University of Pittsburgh are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 643 Alzheimer Disease studies recruiting now, 284 (44%) set no upper age limit and 55 (9%) stop at 75 or younger; 34 take children under 18; 285 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Alzheimer Disease by University of Pittsburgh, or all of them as a file.
02

Study summary

The primary objective of this study is to evaluate the feasibility of using a narrative video game intervention to improve advance care planning (ACP) among care partners of people living with Alzheimer's Disease and Related Dementia. Feasibility will be assessed by evaluating acceptability as well as the fidelity of intervention delivery.

Read the detailed description

The trial is designed to establish the feasibility and plausibility of using the intervention to alter psychological outcomes, necessary to justify a future Type 1 hybrid effectiveness-implementation trial.

03

Conditions studied

  • Alzheimer's Disease and Related Dementias
  • Advance Care Planning

Keywords

  • Alzheimer's Disease
  • Advance Care Planning
  • Narrative Video Game
  • Dementia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be 18 years or older
  • Identify as the primary support person (care partner) for health-related decisions for a person with dementia

Exclusion criteria

Exclusion Criteria:

  • the person with dementia has died
  • the care partner does not have an email address
  • the care partner is unwilling to be recorded
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Pre and Post Intervention (Narrative Video Game) Assessment

    Participants in this arm will complete the Surrogate ACP Readiness Survey prior to intervention exposure. Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey.

    Behavioral: Narrative Video Game

  • Experimental
    Post-Intervention (Narrative Video Game) Assessment Only

    Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey.

    Behavioral: Narrative Video Game

Interventions

  • BehavioralNarrative Video Game

    The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.

    Also known as: ANTICIPATE

06

What researchers measure

Primary outcomes

  1. Acceptability of the intervention (co-primary)

    Proportion of participants who score the intervention as ≥4/5 on the Acceptability of Intervention Measure

    Time frame: Immediately following intervention exposure

  2. Fidelity of intervention delivery (co-primary)

    Proportion of participants who complete all study tasks

    Time frame: 3 months post-intervention exposure

Secondary outcomes

  1. Fidelity of intervention receipt

    Mean responses to the items on the ACP Engagement Survey for Surrogate Decision makers and then summarized by domain (knowledge, readiness, self-efficacy, contemplation).

    Time frame: Pre-intervention to 3 months post-intervention

  2. Fidelity of intervention enactment (self-reported completion of ACP)

    Proportion of participants who report ACP activities after intervention exposure

    Time frame: 3 months post-intervention

  3. Fidelity of behavior change technique delivery

    Proportion of participants who report the use of behavioral rehearsal during the game or who demonstrate the use of rehearsal during game play.

    Time frame: Immediately post-intervention

07

Study locations

1 site
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
    • Deepika Mohan, MD, MPH · Contactmohand@upmc.edu · 412-647-0835
    • Caroline J Pidro · Contactcjl13@pitt.edu · 412-383-0821
    • Deepika Mohan, MD, MPH · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — All collected and de-identified individual participant data.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: It will be made available within 6 months of completion of the study, and will be available for 7 years.

Access criteria: We will upload the data to a data repository (ICPSR), and researchers may access it by following the protocols set by the repository.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for May 2027, 5 months later.

Of 885 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 5 months is below that.

Counting every sponsor, half of 962 studies reached it within 29 months; a quarter within 15 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 17, 2026
StartEst.
Dec 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07940673
Collaborators
National Institute on Aging (NIA), Dartmouth College
Responsible party
Deepika Mohan (Associate Professor, University of Pittsburgh) — Principal investigator
First posted
Nov 17, 2026
Start date
Dec 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Deepika Mohan, MD, MPH
Contact
mohand@upmc.edu
412-647-0835
Caroline J Pidro
Contact
cjl13@pitt.edu
412-383-0821
Amber Barnato, MD, MPH, MS
principal investigator · Dartmouth College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion